9.90
Xeris Biopharma Holdings Inc Borsa (XERS) Ultime notizie
Why Xeris Biopharma Holdings Inc. (2B30) stock is listed among top recommendations - newser.com
Is a relief rally coming for Xeris Biopharma Holdings Inc. holdersQuarterly Portfolio Report & AI Powered Market Entry Strategies - newser.com
Why Xeris Biopharma Holdings Inc. (2B30) stock appeals to dividend investorsTreasury Yields & Weekly Chart Analysis and Trade Guides - newser.com
Can Xeris Biopharma Holdings Inc. stock maintain growth trajectory2025 Big Picture & Breakout Confirmation Trade Signals - newser.com
How higher bond yields impact Xeris Biopharma Holdings Inc. (2B30) stockMarket Risk Analysis & Real-Time Stock Entry Alerts - newser.com
Can Xeris Biopharma Holdings Inc. stock maintain operating marginsWatch List & Safe Capital Investment Plans - newser.com
How sentiment analysis helps forecast Xeris Biopharma Holdings Inc.July 2025 Sentiment & Stock Market Timing Techniques - newser.com
Why Xeris Biopharma Holdings Inc. (2B30) stock could be top winnerLayoff News & High Conviction Buy Zone Picks - newser.com
Applying chart zones and confluence areas to Xeris Biopharma Holdings Inc.2025 Trade Ideas & Fast Exit and Entry Trade Guides - newser.com
Is Xeris Biopharma Holdings Inc. (2B30) stock supported by strong fundamentalsQuarterly Trade Review & AI Forecast for Swing Trade Picks - newser.com
Xeris Biopharma (NASDAQ:XERS) Downgraded to Hold Rating by Zacks Research - MarketBeat
Y Intercept Hong Kong Ltd Acquires 291,696 Shares of Xeris Biopharma Holdings, Inc. $XERS - MarketBeat
What high frequency data says about Xeris Biopharma Holdings Inc.2025 Market WrapUp & Free Technical Confirmation Trade Alerts - newser.com
Xeris Biopharma Hits New 52-Week High of $10.03, Up 314.66% - Markets Mojo
Is Xeris Biopharma Holdings Inc. stock entering bullish territoryJuly 2025 Sentiment & Fast Exit Strategy with Risk Control - newser.com
Using R and stats models for Xeris Biopharma Holdings Inc. forecasting2025 Market Trends & Technical Confirmation Trade Alerts - newser.com
Xeris Biopharma (XERS) Projected to Post Quarterly Earnings on Thursday - MarketBeat
Is Xeris Biopharma Holdings Inc. stock undervalued vs historical averagesWeekly Investment Summary & Low Risk High Reward Trade Ideas - newser.com
Detecting support and resistance levels for Xeris Biopharma Holdings Inc.Market Activity Recap & Accurate Technical Buy Alerts - newser.com
Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Xeris Biopharma (NASDAQ:XERS) Hits New 1-Year HighStill a Buy? - MarketBeat
Is Xeris Biopharma Holdings Inc. (2B30) stock cheap vs fundamentals2025 Market WrapUp & Daily Profit Maximizing Trade Tips - newser.com
Xeris Biopharma Hits New 52-Week High of $9.48, Up 297% Year-Over-Year - Markets Mojo
Oppenheimer Adjusts Price Target on Xeris Biopharma to $18 From $8, Maintains Outperform Rating - MarketScreener
What Xeris Biopharma Holdings (XERS)'s Strong Revenue Growth and Pipeline Advances Mean For Shareholders - simplywall.st
How Phase 3 XP-8121 Progress at Xeris Biopharma Holdings (XERS) Has Changed Its Investment Story - Yahoo Finance
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):